HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Qiora distribution

This article was originally published in The Rose Sheet

Executive Summary

Shiseido closed its New York City Qiora Center for Total Beautification in February as part of a business realignment, Japanese firm says. Based on sales and consumer response, Qiora will be sold in the U.S. exclusively in 70 independent perfumeries, Shiseido adds, noting it has also phased out its limited department store distribution. Strategy "will allow the company to focus its resources in a distribution channel that has demonstrated high growth potential and high consumer acceptance," the company states. Qiora launched in the New York City store in 2001 and later expanded into limited department store distribution in places like Saks Fifth Avenue and Bergdorf Goodman (1"The Rose Sheet" Aug. 27, 2001, p. 4). Department store distribution in the last year had been fewer than 10 doors...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel